|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.930 USD | -2.01% |
|
-2.98% | -18.84% |
| 07-07 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 06-29 | Altimmune, Inc.(NasdaqGM:ALT) dropped from Russell Small Cap Comp Growth Benchmark | CI |
| Market Cap | 570M 498M 460M 425M 801M 54.73B 815M 5.49B 2.15B 26.8B 2.14B 2.09B 92.28B | P/E 2026 * |
-4.35x | P/E 2027 * | -3.87x |
|---|---|---|---|---|---|
| Enterprise Value | 187M 163M 151M 139M 263M 17.94B 267M 1.8B 706M 8.78B 702M 686M 30.25B | EV / Sales 2026 * |
45,555x | EV / Sales 2027 * | - |
| Free-Float |
99.59% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Altimmune, Inc.
| 1 day | -2.01% | ||
| 1 week | -2.98% | ||
| Current month | -3.62% | ||
| 1 month | +12.26% | ||
| 3 months | -10.94% | ||
| 6 months | -29.90% | ||
| Current year | -18.84% |
| 1 week | 2.9 |  | 3.15 |
| 1 month | 2.6 | | 3.4 |
| Current year | 2.56 | | 6.44 |
| 1 year | 2.56 | | 6.44 |
| 3 years | 2.09 | | 14.84 |
| 5 years | 2.09 | | 23.49 |
| 10 years | 1.51 | | 237.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jerome Durso
CEO | Chief Executive Officer | 58 | 2025-12-31 |
Gregory Weaver
DFI | Director of Finance/CFO | 70 | 2024-11-10 |
Rachel Garner
CTO | Chief Tech/Sci/R&D Officer | - | 2025-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Philip Hodges
BRD | Director/Board Member | 58 | 2003-08-31 |
Mitchel Sayare
CHM | Chairman | 78 | 2017-12-31 |
Klaus Schafer
BRD | Director/Board Member | 76 | 2012-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-30 | Free | Director | 48,800 | 0.0251% | ||
| 04-30 | Free | Director | 48,800 | 0.0251% | ||
| 04-30 | Free | Director | 48,800 | 0.0251% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.01% | -2.98% | -31.22% | -10.67% | 581M | |
| +0.21% | -6.28% | +56.18% | +127.90% | 54.18B | |
| +6.05% | +7.79% | +62.23% | +88.46% | 53.54B | |
| +0.89% | -2.42% | +8.07% | +434.51% | 23.66B | |
| +0.37% | -4.13% | -18.56% | -16.48% | 22.78B | |
| +4.19% | +11.61% | +45.79% | -2.57% | 19.54B | |
| -2.29% | -1.92% | +35.57% | -29.14% | 17.82B | |
| -4.00% | -10.96% | +181.91% | +328.17% | 16.01B | |
| +10.80% | +15.04% | +54.22% | +743.92% | 15.37B | |
| -0.48% | -2.30% | +22.36% | +187.62% | 14.09B | |
| Average | +1.36% | -1.94% | +41.65% | +185.17% | 23.76B | |
| Weighted average by Cap. | +2.10% | -0.62% | +49.31% | +169.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.1K 3.58K 3.31K 3.06K 5.76K 394K 5.87K 39.5K 15.5K 193K 15.4K 15.06K 664K | - |
| Net income | -112M -97.69M -90.31M -83.43M -157M -10.74B -160M -1.08B -423M -5.26B -420M -411M -18.1B | -139M -122M -112M -104M -196M -13.37B -199M -1.34B -526M -6.55B -523M -511M -22.55B |
| Net Debt | -383M -335M -309M -286M -538M -36.79B -548M -3.69B -1.45B -18.02B -1.44B -1.41B -62.03B | -256M -224M -207M -191M -360M -24.59B -366M -2.47B -968M -12.04B -961M -940M -41.45B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-14 | US$2.930 | -2.01% | 3,297,857 |
| 26-07-13 | US$2.990 | -1.97% | 2,457,098 |
| 26-07-10 | US$3.050 | -2.24% | 2,992,854 |
| 26-07-09 | US$3.120 | +0.32% | 2,876,992 |
| 26-07-08 | US$3.110 | +2.98% | 3,520,264 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
